Which combination inhaler is approved for the Single Maintenance And Reliever Therapy (SMART) protocol?
Answer
Budesonide/Formoterol (e.g., Symbicort)
The Single Maintenance And Reliever Therapy (SMART), also known as Maintenance and Reliever Therapy (MART), requires a specific combination inhaler that contains both an Inhaled Corticosteroid (ICS) and the fast-acting Long-Acting Beta Agonist (LABA) formoterol. The key product approved and utilized for this dual role is the Budesonide/Formoterol combination, found in products like Symbicort. This allows the patient to use the same inhaler both daily as a controller (where Budesonide manages inflammation) and as a rescue medication when needed (where the fast-acting Formoterol provides immediate bronchodilation), eliminating the need for a separate, traditional reliever inhaler.
Related Questions
What is the primary function of preventers or controllers in asthma management?Which medication class forms the cornerstone of long-term asthma control?For combination inhalers, why must LABAs be paired with a corticosteroid?Which brand name corresponds to the ICS medication Ciclesonide?What component is added to an ICS and LABA to create triple therapy preventers?How do Leukotriene Modifiers, like Montelukast, work to prevent asthma symptoms?Which combination inhaler is approved for the Single Maintenance And Reliever Therapy (SMART) protocol?What specific driver of inflammation does Omalizumab (Xolair) primarily target?Why might a patient prefer a dry powder device like Ellipta over an Advair MDI requiring a spacer?What did one review state about the strength of a particular Fluticasone HFA formulation?